ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sifrol ER 3,0 mg, Retardtabletten - 30 Tablette(n)
60057005 Boehringer Ingelheim (Schweiz) GmbH
Sifrol ER 3,0 mg, Retardtabletten10.06.2010
Original10.06.2010
Pramipexole (N04BC05) 
WHO-DDD 
01.08.30 Tablette(n)
01.08. 
B  
Yes 
IPCI
110.06Yes
    
10 %135.10
7680600570054Synthetika
4612214 
Composition
pramipexoli dihydrochloridum monohydricum 3.00 mg corresp. pramipexolum 2.097 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Pramipexol Dihydrochloride Monohydrate3 mg correspond Pramipexol 2.097 mg
BAG: Active AgentDose
Pramipexol Dihydrochloride Monohydrate3 mg
 
Inactive agentsDose
Carbomer941
Hypromellosum 
Magnesii Stearas pro Compresso 
Maydis Amylum 
Silica Colloidalis Anhydrica 
 
Source
Data was imported : 05.03.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home